Nabriva Therapeutics plc (NBRVF)

OTCMKTS: NBRVF · Delayed Price · USD
0.0000
-0.0002 (-99.50%)
Mar 12, 2024, 3:08 PM EDT - Market open

Nabriva Therapeutics Market Cap

Nabriva Therapeutics has a market cap or net worth of $1.66 million as of March 28, 2024. Its market cap has decreased by -98.47% in one year.

Market Cap
1.66M
Enterprise Value
-50.24K
1-Year Change
-98.47%
Ranking
n/a
Category
Stock Price
$0.00

Market Cap Chart

Since September 18, 2015, Nabriva Therapeutics's market cap has decreased from $262.20M to $1.66M, a decrease of -99.37%. That is a compound annual growth rate of -47.42%.

History

DateMarket Cap% Change
Jul 31, 202345.50M-
Jul 28, 202345.50M-2.36%
Jul 27, 202346.60M-0.21%
Jul 26, 202346.70M-0.85%
Jul 25, 202347.10M-9.25%
Jul 24, 202351.90M-
Jul 21, 202351.90M-0.19%
Jul 20, 202352.00M-5.45%
Jul 19, 202355.00M3.58%
Jul 18, 202353.10M1.72%
Jul 17, 202352.20M2.96%
Jul 14, 202350.70M2.22%
Jul 13, 202349.60M1.85%
Jul 12, 202348.70M0.41%
Jul 11, 202348.50M-2.41%
Jul 10, 202349.70M4.85%
Jul 7, 202347.40M-4.44%
Jul 6, 202349.60M3.33%
Jul 5, 202348.00M-3.03%
Jul 3, 202349.50M2.48%
Jun 30, 202348.30M-0.41%
Jun 29, 202348.50M5.90%
Jun 28, 202345.80M-2.35%
Jun 27, 202346.90M-4.29%
Jun 26, 202349.00M-0.81%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 735.08B
Novo Nordisk 579.01B
UnitedHealth Group 450.04B
Johnson & Johnson 374.05B
AbbVie 316.43B
Merck & Co. 313.67B
Thermo Fisher 222.34B
AstraZeneca 205.55B
Market Cap Rankings